- decreased granulocyte number / IMPC
- decreased mean corpuscular volume / IMPC
- decreased heart weight / IMPC
- abnormal bone mineralization / IMPC
- abnormal bone structure / IMPC
- increased circulating creatinine level / IMPC
- decreased circulating glucose level / IMPC
- decreased mean corpuscular hemoglobin concentration / IMPC
- increased bone mineral content / IMPC
C57BL/6NTac-Eif2b5tm1a(EUCOMM)Wtsi/IcsOrl
Status | Available to order |
EMMA ID | EM:07702 |
International strain name | C57BL/6NTac-Eif2b5tm1a(EUCOMM)Wtsi/IcsOrl |
Alternative name | EPD0116_1_C09 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Eif2b5tm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Eif2b5 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | ICS, Institut Clinique de la Souris |
Provider affiliation | ICS, Institut Clinique de la Souris |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0116_1_C09. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Animals used for archiving | heterozygous C57BL/6NTac |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Congenital or early infantile CACH syndrome / Orphanet_157713
- Late infantile CACH syndrome / Orphanet_157716
- Ovarioleukodystrophy / Orphanet_99853
- Juvenile or adult CACH syndrome / Orphanet_157719
- Cree leukoencephalopathy / Orphanet_99854
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased mean corpuscular volume / IMPC
- increased bone mineral content / IMPC
- abnormal bone mineralization / IMPC
- decreased granulocyte number / IMPC
- decreased mean corpuscular hemoglobin concentration / IMPC
- abnormal bone structure / IMPC
- decreased circulating glucose level / IMPC
- increased circulating creatinine level / IMPC
- decreased heart weight / IMPC
MGI phenotypes (gene matching)
- abnormal forebrain morphology / MGI
- abnormal myelination / MGI
- demyelination / MGI
- sporadic seizures / MGI
- decreased body weight / MGI
- abnormal retina morphology / MGI
- ataxia / MGI
- impaired coordination / MGI
- premature death / MGI
- abnormal astrocyte morphology / MGI
- ectopic Bergmann glia cells / MGI
- abnormal locomotor activation / MGI
- abnormal microglial cell physiology / MGI
- abnormal retinal outer nuclear layer morphology / MGI
- abnormal retinal inner nuclear layer morphology / MGI
- abnormal axon morphology / MGI
- decreased percent body fat/body weight / MGI
- brain vacuoles / MGI
- abnormal brain white matter morphology / MGI
- abnormal brain internal capsule morphology / MGI
- thin retinal inner plexiform layer / MGI
- abnormal physiological response to xenobiotic / MGI
- abnormal astrocyte physiology / MGI
- decreased oligodendrocyte number / MGI
- abnormal cerebellum white matter morphology / MGI
- decreased grip strength / MGI
- increased oligodendrocyte number / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).